Comments
Drug firm AstraZeneca Pharma India on Monday reported a 45.03 per cent decline in its net profit to ₹10.24 crore for the June ended quarter.
The company had posted a net profit of ₹18.63 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.
Revenue from operations stood at ₹175.40 crore for the quarter. It was ₹193.57 crore for the same period a year ago, it added.
The company's board of directors has declared an interim dividend of ₹2 per equity share for the financial year 2021-22, the filing said.
Shares of AstraZeneca Pharma India closed at ₹3,364.45 per scrip on BSE, down 1.23 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.